Canopy Growth Corp vs Xpeng Inc - ADR — how do they compare? Canopy Growth Corp trades at $0.98 (market cap $398.46M), while Xpeng Inc - ADR trades at $14.18 (market cap $12.77B). The key difference: Xpeng Inc - ADR is far larger — about 32× Canopy Growth Corp's market cap. Which is the better fit depends on your goals.
| CGC | XPEV | |
|---|---|---|
Market Cap | $398.46M | $12.77B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.92 | $28.07 |
52-Week Low | $0.86 | $12.09 |
Enterprise Value | $337.90M | $14.88B |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
XPeng (XPEV) trades at $12.95, down 0.61% today, with a bearish technical signal from moving averages. The company reported strong Q2 2026 deliveries of 103,295 vehicles, beating guidance, but continues to post net losses with a -3.06% margin. Revenue grew to $76.72B in 2025, though cash flow from operations was negative $2.01B in 2024. Analyst sentiment is mixed with 64.7% buy ratings.
The outlook hinges on XPeng's ability to achieve profitability amid expansion. Opportunities include new model launches and international growth, but risks persist from intense EV competition and ongoing cash burn. The stock's valuation at P/S of 1.14 may attract value investors if margins improve.
Trailing returns across standard periods
Latest headlines on both assets
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Read more on XPEV →